Frank Moss PhD

Frank Moss PhD

Principal Investigator

Frank Moss served as director of the MIT Media Lab and the Jerome B. Wiesner Professor of Media Arts and Sciences from 2006 to 2011. An entrepreneur and 25-year veteran of the computer and biotech industries, Moss spent most of his career bringing innovative business technologies to market. At the Media Lab, he’s been seeking something different: how to use technology to address pressing social problems and to improve quality of life for people worldwide. Moss and his colleagues at the Media Lab envision a globally connected digital society that makes people smarter, healthier, and more creative. The Lab is conducting research on technologies that extend and enhance people's physical, cognitive and social capabilities; robots that can relate to people in more human terms; and organically decentralized networks that unlock people’s creative, innovative and problem-solving powers. Under his direction the New Media Medicine group is exploring how these technologies and others can revolutionize health care through radical new collaborations between doctors, patients and communities.

Before joining MIT, Moss co-founded Infinity Pharmaceuticals, Inc., an early-stage cancer-drug discovery company doing innovative work at the intersection of technology and the life sciences; he remains on the board there. In addition, he chaired the advisory council for the creation of the Systems Biology Department at Harvard Medical School. Previously, he was CEO and chairman of Tivoli Systems Inc., which he took public in 1995 and sold to IBM in 1996, and co-founder of several other technology companies. He began his career at IBM's scientific center in Haifa, Israel, and later held various research and management positions at IBM's Yorktown Heights (NY) Research Center. Moss is a 1971 graduate of Princeton University, where he currently serves as a member of the board of trustees; and received master’s and PhD degrees from MIT in 1972 and 1976, respectively.